Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Recruiting · NCT05658081 · Interventional (participants receive a specific treatment) · Lead sponsor: Jinling Hospital, China
View the official record on ClinicalTrials.gov →Interventions studied
Kono-S groupSide-to-side group
What this trial is about
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.
Who can take part
Age range
16 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients with Crohn's disease needing bowel resection and anastomosis;
- ileocolic anastomosis；
- written consent acquired
Exclusion criteria
- patients underwent enterostomy;
- small bowel anastomosis;
- anticipating other trial.
Where it is running
1 location listed.
- Department of General Surgery, Jinling hosptal,Medical School of Nanjing University - Nanjing, Jiangsu, China